On paper, it sounds extremely effective
Preclinical studies using metabolic assays such as euglycemic clamp techniques indicate that AOD 9604 does not impair insulin-mediated glucose uptake in adipose or peripheral tissues
Arun Sanyal, M.D., a hepatologist who is director of the VCU Stravitz-Sanyal Institute for Liver Disease and Metabolic Health
A landmark clinical trial published in the Journal of Clinical Endocrinology and Metabolism demonstrating that Ipamorelin produces selective GH release without significant cortisol or prolactin elevation, establishing its safety profile for use in women with hormonally sensitive physiological backgrounds is the foundational study that shaped how the peptide is used today in supervised clinical settings
There are many multidisciplinary approaches to weight loss such as physical activity, a healthy diet and medical treatment
However, there are some very real risks related to using compounded drugs, in general